Skip to main content
Top
Published in: Journal of Inflammation 1/2013

Open Access 01-08-2013 | Poster presentation

Mouse model of HDM induced airway inflammation + influenza or RSV. Effects of steroid

Authors: Dave Lamb, Christina Muir, Debbie Chappell, Hiroki Mori, Nicole Parker, Katy Hulland, Dominique Westbrook, Umar Burki, Jenny Hincks, Tony White, Vittorio Spampinato, Helen Bright, Steve Evans

Published in: Journal of Inflammation | Special Issue 1/2013

Login to get access

Excerpt

Influenza A virus is one of the most common infectious pathogens. The disease that ensues is particularly serious in certain at risk groups within the population; such as individuals with chronic respiratory and cardiovascular diseases. Asthma is an example of a chronic inflammatory disease which is exacerbated by the virus, and infection frequently leads to hospitalization of asthmatic patients. The role of respiratory viruses in development of severe clinical asthma, in particular, is poorly understood. Pfizer has supported the European Union-led IMI UBIOPRED pre-competitive collaboration between academic and pharma partners which aims to better understand the clinical disease, and in doing so, developed pre-clinical models of both severe asthma and asthma exacerbation. We established and characterised RSV and Influenza A infection in the mouse house dust mite (HDM) model. …
Metadata
Title
Mouse model of HDM induced airway inflammation + influenza or RSV. Effects of steroid
Authors
Dave Lamb
Christina Muir
Debbie Chappell
Hiroki Mori
Nicole Parker
Katy Hulland
Dominique Westbrook
Umar Burki
Jenny Hincks
Tony White
Vittorio Spampinato
Helen Bright
Steve Evans
Publication date
01-08-2013
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue Special Issue 1/2013
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-10-S1-P22

Other articles of this Special Issue 1/2013

Journal of Inflammation 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.